Antonio Freire

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clóvis Arns da Cunha et al. · The Lancet · 2007 · 689 citations

Life Sciences, Infectious Diseases, Microbiology +17

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

Antonio Freire, Vasyl Melnyk, Min Ja Kim et al. · Diagnostic Microbiology and Infectious Disease · 2010 · 287 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis

Flávio Queiroz‐Telles, Eitan Naaman Berezin, Guy Leverger et al. · The Pediatric Infectious Disease Journal · 2008 · 215 citations

Pharmacy, Pediatrics, Pharmacotherapy +17

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen et al. · The Lancet Respiratory Medicine · 2022 · 142 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +12

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study

William O’Riordan, Alison J. McManus, Jüri Teras et al. · Clinical Infectious Diseases · 2018 · 105 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15